https://www.pharmacytimes.com/view/from-setbacks-to-solutions-pioneering-safe-rsv-vaccines-for-infants-children
With respiratory syncytial virus vaccine development for infants and children proceeding slowly, therapeutic developers have focused on passive immunity
Create an account or login to join the discussion